Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announced the appointment of Karen Harrison as Chief Operating Officer of its Therapeutics Division. In her new role, Karen will be responsible for supporting the research and development functions across Avacta’s Therapeutics Division, with her focus exclusively on creating maximum value for the Group’s stakeholders. Latest clinical data for the Company’s...